Correlation Between Chemours and Morgan Stanley

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chemours and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chemours and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chemours Co and Morgan Stanley, you can compare the effects of market volatilities on Chemours and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chemours with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chemours and Morgan Stanley.

Diversification Opportunities for Chemours and Morgan Stanley

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Chemours and Morgan is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Chemours Co and Morgan Stanley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley and Chemours is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chemours Co are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley has no effect on the direction of Chemours i.e., Chemours and Morgan Stanley go up and down completely randomly.

Pair Corralation between Chemours and Morgan Stanley

Allowing for the 90-day total investment horizon Chemours Co is expected to generate 3.28 times more return on investment than Morgan Stanley. However, Chemours is 3.28 times more volatile than Morgan Stanley. It trades about -0.05 of its potential returns per unit of risk. Morgan Stanley is currently generating about -0.23 per unit of risk. If you would invest  1,905  in Chemours Co on September 19, 2024 and sell it today you would lose (84.00) from holding Chemours Co or give up 4.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Chemours Co  vs.  Morgan Stanley

 Performance 
       Timeline  
Chemours 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chemours Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Chemours is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Morgan Stanley 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Morgan Stanley unveiled solid returns over the last few months and may actually be approaching a breakup point.

Chemours and Morgan Stanley Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chemours and Morgan Stanley

The main advantage of trading using opposite Chemours and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chemours position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.
The idea behind Chemours Co and Morgan Stanley pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios